Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Morningside SPV
Hong Kong, Hong Kong
- Ownership
- Private
- Development stage
- Other
01
Overview
Morningside Group is a private investment group founded in 1986 by the Chan family of Hong Kong. The firm is a prominent investor in the life sciences and biotechnology sectors, often acting as a company builder by providing seed and early-stage capital to startups. Morningside is known for its long-term investment horizon and active involvement in its portfolio companies, which include notable biotechs such as Apellis Pharmaceuticals, Stealth BioTherapeutics, and Viela Bio. The group operates globally with offices in Hong Kong, Shanghai, and the United States, focusing on innovative technologies that address significant unmet medical needs.
- Industry
- Investors
Beyond the preview
Go deeper on Morningside SPV.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Morningside SPV.